Like most chemotherapeutic drugs, the first-line chemotherapeutic drug for lung cancer, cisplatin (CDDP), is not able to induce ICD because it cannot induce the exposure of calreticulin (CRT) on the cell surface [11]. The gene discussed is CALR; the disease is lung cancer.